Eileen Patricia Connolly MD
Assistant Professor, Radiation Oncology, Columbia University College of Phys & Surg
622 W 168th StNew York, NY 10032
Fax+1 212-305-5935
Overview of Dr. Connolly
Dr. Eileen Connolly is a Radiation Oncology specialist based in New York, NY. She is a graduate of the New York University School of Medicine where she also completed her internship in Internal Medicine and residency in Radiation Oncology. Dr. Connolly has numerous publications in well-known clinical journals focusing on high-risk neuroblastoma, hormone receptor/HER2+ early-stage breast cancer, intraoperative radiotherapy for breast cancer, and more. These research papers have received citations from various other publications, demonstrating her significant contribution to her field. Being an active clinical researcher, she is involved in multiple clinical trials primarily addressing aspects related to breast cancer treatment.
Education & Training
NYU Grossman School of MedicineResidency, Radiation Oncology, 2007 - 2011- NYU Grossman School of MedicineInternship, Internal Medicine, 2006 - 2007
- New York University School of MedicineClass of 2006
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 2008 - 2026
CT State Medical License 2022 - 2025
American Board of Radiology Radiation Oncology
Clinical Trials
- Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery Start of enrollment: 2012 May 18
- Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer Start of enrollment: 2017 Oct 25
- Comparison of the Breast Tumor Microenvironment Start of enrollment: 2017 Sep 28
Publications & Presentations
PubMed
- 1 citationsSpatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial.Yee Hoon Foong, Qi Wang, Matthew Kearney, Hortense Le, Hua Guo
NPJ Breast Cancer. 2025-07-17 - 1 citationsNRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.Lior Z Braunstein, Melissa P Mitchell, Hanna Bandos, William M Sikov, Atif J Khan
Future Oncology. 2025-07-01 - 1 citationsCLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High Risk.Chirag Shah, Frank A Vicini, Eileen P Connolly, Rachel A Rabinovitch, Brian Czerniecki
Journal of the National Comprehensive Cancer Network. 2025-03-28
Journal Articles
- Comparing Preoperative Imaging Modalities in Patient Selection for Breast Intraoperative RadiotherapyEileen P Connolly, Richard Ha, David Horowitz, Christine Chin, Journal of Surgical Oncology
- Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network AlgorithmSimukayi Mutasa, Eileen Connolly, Richard Ha, Christine Chin, Bret Taback, Annals of Surgical Oncology
Press Mentions
Research Efforts Continue with Radiation Therapy in Breast CancerFebruary 5th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
